Evidence map›Paper›PMID 30719623›Full record

ArticleJournal of endocrinological investigation2019

Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy?

M L Tanda, E Piantanida, E Masiello, C Cusini, L Bartalena

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Current concepts regarding Graves' orbitopathy.Journal of internal medicine · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M L TandaEndocrine Unit, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Viale Borri, 57, 21100, Varese, Italy.
E PiantanidaEndocrine Unit, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Viale Borri, 57, 21100, Varese, Italy.
E MasielloEndocrine Unit, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Viale Borri, 57, 21100, Varese, Italy.
C CusiniEndocrine Unit, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Viale Borri, 57, 21100, Varese, Italy.
L BartalenaEndocrine Unit, ASST dei Sette Laghi, Department of Medicine and Surgery, University of Insubria, Viale Borri, 57, 21100, Varese, Italy. luigi.bartalena@uninsubria.it.
University of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graves OphthalmopathyGlucocorticoidsHumansMethylprednisoloneSeverity of Illness IndexGlucocorticoidsMethylprednisoloneCyclosporineGraves’ orbitopathyIntravenous glucocorticoidsMethotrexate

Identifiers

PMID30719623
OpenAlexW2914776081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.